header
Image from OpenLibrary

A comparative study between the effect of laparoscopic sleeve gastrectomy and laparoscopic one anastomosis gastric bypass on glucagon like peptide-1 (GLP-1) / Abdelrahman Yehia Ahmed ; Supervised Hisham Ahmed Aboueisha , Mohamed Diaa Eldein Sarhan , Ahmed Mohamed Abdelsalam

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Abdelrahman Yehia Ahmed , 2021Description: 94 P. : charts , facsimiles ; 25cmOther title:
  • مقارنة بين تأثير عمليه تكميم المعدة بالمنظار وعمليه تحويل المسار المصغر بالمنظار على البيبتيد الجلوكاجون -١ [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of General Surgery Summary: Introduction Bariatric surgery is the most effective treatment for patients with severe obesity (body mass index of Greater than or equal 40 kg/m2), both in terms of weight loss and improvements in obesity-related diseases such as Type 2 diabetes (T2D). The mechanisms underlying the beneficial effects of bariatric surgery are now the focus of a burgeoning field of research, with the aim of developing new therapies for obesity and T2D. In this regard, there has been an increasing interest in the role that gut hormones may play in mediating the physiological changes produced by certain bariatric procedures, such as sleeve gastrectomy and one anastomosis gastric bypass. Methods This is a Prospective comparative study that included 40 T2D patients. Patients were divided into two groups; 20 of them underwent sleeve gastrectomy, and the other 20 underwent one anastomosis gastric bypass, the selected patients were followed up. measuring fasting GLP-1 one day preoperative, three month and one year postoperative in both sleeve gastrectomy and one anastomosis gastric bypass. In addition to measuring HbA1c one day preoperative, three month and one year postoperative in both sleeve gastrectomy and one anastomosis gastric bypass. Initial weight & extent of weight loss were also measured. Results In our study, we found the following, first regarding percentage of excess weight loss (%EWL), in the sleeve gastrectomy group; we observed that there is a statistically significant increase in %EWL over a period of one year postoperatively (p value < 0.001), with a mean %EWL of 31.24% three months postoperatively and a mean %EWL of 58.95% one year postoperatively, While in the one anastomosis gastric bypass group; there is a statistically significant increase in the %EWL over a period of one year postoperatively (p value < 0.001), where the mean %EWL three months postoperatively was 31.73% with furthermore increase in %EWL one year postoperatively with a mean of 64.86%. second regarding glucagon like peptide 1 (GLP-1) In the sleeve gastrectomy subjects
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.14.Ph.D.2021.Ab.C (Browse shelf(Opens below)) Not for loan 01010110083671000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.14.Ph.D.2021.Ab.C (Browse shelf(Opens below)) 83671.CD Not for loan 01020110083671000

Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of General Surgery

Introduction Bariatric surgery is the most effective treatment for patients with severe obesity (body mass index of Greater than or equal 40 kg/m2), both in terms of weight loss and improvements in obesity-related diseases such as Type 2 diabetes (T2D). The mechanisms underlying the beneficial effects of bariatric surgery are now the focus of a burgeoning field of research, with the aim of developing new therapies for obesity and T2D. In this regard, there has been an increasing interest in the role that gut hormones may play in mediating the physiological changes produced by certain bariatric procedures, such as sleeve gastrectomy and one anastomosis gastric bypass. Methods This is a Prospective comparative study that included 40 T2D patients. Patients were divided into two groups; 20 of them underwent sleeve gastrectomy, and the other 20 underwent one anastomosis gastric bypass, the selected patients were followed up. measuring fasting GLP-1 one day preoperative, three month and one year postoperative in both sleeve gastrectomy and one anastomosis gastric bypass. In addition to measuring HbA1c one day preoperative, three month and one year postoperative in both sleeve gastrectomy and one anastomosis gastric bypass. Initial weight & extent of weight loss were also measured. Results In our study, we found the following, first regarding percentage of excess weight loss (%EWL), in the sleeve gastrectomy group; we observed that there is a statistically significant increase in %EWL over a period of one year postoperatively (p value < 0.001), with a mean %EWL of 31.24% three months postoperatively and a mean %EWL of 58.95% one year postoperatively, While in the one anastomosis gastric bypass group; there is a statistically significant increase in the %EWL over a period of one year postoperatively (p value < 0.001), where the mean %EWL three months postoperatively was 31.73% with furthermore increase in %EWL one year postoperatively with a mean of 64.86%. second regarding glucagon like peptide 1 (GLP-1) In the sleeve gastrectomy subjects

Issued also as CD

There are no comments on this title.

to post a comment.